Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002

被引:77
作者
Ubukata, K
Chiba, N
Hasegawa, K
Kobayashi, R
Iwata, S
Sunakawa, K
机构
[1] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan
[2] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan
[3] Tokyo Natl Med Ctr, Dept Pediat, Meguro Ku, Tokyo, Japan
[4] Meiji Seika Kaisha Ltd, Pharmaceut Ctr, Kohoku Ku, Yokohama, Kanagawa, Japan
关键词
D O I
10.1128/AAC.48.5.1488-1494.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antibiotic susceptibilities, genotypes of penicillin (PEN)-binding protein genes (pbp), and serotype distributions of Streptococcus pneumoniae isolates from meningitis patients were investigated by a nationwide surveillance group in Japan between 1999 and 2002. We analyzed 146 isolates from children (less than or equal to17 years old) and 73 from adults (greater than or equal to18 years old). Isolates with or without abnormal pbpla, pbp2x, or pbp2b genes identified by PCR were classified into six genotype patterns and 90% MIC (MIC90) values for PEN: (i) strains with three normal genes (17.2% of isolates; MIC90, 0.031 mug/ml); (ii) strains with abnormal pbp2x (22.1%, 0.063 mug/ml); (iii) strains with abnormal pbp2b (1.0%, 0.125 mug/ml); (iv) strains with abnormal pbp2x and pbp2b (7.4%, 0.25 mug/ml); (v) strains with abnormal pbpla and pbp2x (12.7%, 0.25 mug/ml); and (vi) strains with three abnormal PBP genes (39.7%, 4 mug/ml), which are termed genotypic PEN-resistant S. pneumoniae (gPRSP). Panipenem, a carbapenem, showed an excellent MIC,, (0.125 mug/ml) against gPRSP, followed by meropenem and vancomycin (0.5 mug/ml), cefotaxime and ceftriaxone (1 mug/ml), and ampicillin (4 mug/ml). Strains of gPRSP were significantly more prevalent in children (45.2%) than in adults (27.4%). The most frequent serotypes were 6B, 19F, 23F, 6A, and 14 in children and 23F, 22, 3, 10, 6B, and 19F in adults. Serotypes 6B, 6A, 19F, 23F, and 14 predominated among gPRSP. In children, 7- and 11-valent pneumococcal conjugate vaccines would cover 76.2 and 81.3% of isolates, respectively, although coverage would be lower in adults (43.9 and 56.0%, respectively). These findings suggest the need for early introduction of pneumococcal conjugate vaccines and continuous bacteriological surveillance for meningitis.
引用
收藏
页码:1488 / 1494
页数:7
相关论文
共 47 条
[1]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[2]  
[Anonymous], M100S10 NCCLS
[3]  
APPELBAUM PC, 1977, LANCET, V2, P995
[4]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[5]  
Arimasu O, 1988, Kansenshogaku Zasshi, V62, P682
[6]   Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae [J].
Asahi, Y ;
Ubukata, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2267-2273
[7]   Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates [J].
Asahi, Y ;
Takeuchi, Y ;
Ubukata, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1252-1255
[8]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[9]   Appropriateness of a pneumococcal conjugate vaccine in Brazil: Potential impact of age and clinical diagnosis, with emphasis on meningitis [J].
Brandileone, MCC ;
de Andrade, ALSS ;
Di Fabio, JL ;
Guerra, MLLS ;
Austrian, R .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (08) :1206-1212
[10]   Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations [J].
Camou, T ;
Palacio, R ;
Di Fabio, JL ;
Hortal, A .
VACCINE, 2003, 21 (17-18) :2093-2096